Aptamer Sciences Inc (KOSDAQ: 291650)
South Korea
· Delayed Price · Currency is KRW 2,045.00
-130.00 (-5.98%)
Sep 10, 2024, 9:00 AM KST
Aptamer Sciences Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Other Revenue | -0 | -0 | - | - | 0 | - | Upgrade
|
| Revenue | 216.07 | 243.19 | 358.25 | 269.28 | 228.51 | 407.59 | Upgrade
|
| Revenue Growth (YoY) | -42.70% | -32.12% | 33.04% | 17.84% | -43.94% | 47.41% | Upgrade
|
| Cost of Revenue | 45.87 | 52.1 | 71.67 | 112.86 | 71.06 | - | Upgrade
|
| Gross Profit | 170.2 | 191.08 | 286.58 | 156.41 | 157.44 | 407.59 | Upgrade
|
| Selling, General & Admin | 2,851 | 2,746 | 2,289 | 2,024 | 1,988 | 1,913 | Upgrade
|
| Research & Development | 8,944 | 9,359 | 6,025 | 1,763 | 1,770 | 1,446 | Upgrade
|
| Other Operating Expenses | - | - | - | - | - | 79.51 | Upgrade
|
| Operating Expenses | 12,082 | 12,398 | 8,606 | 4,224 | 4,080 | 3,699 | Upgrade
|
| Operating Income | -11,912 | -12,207 | -8,320 | -4,067 | -3,923 | -3,292 | Upgrade
|
| Interest Expense | -1,462 | -1,394 | -299.08 | -24.91 | -7.32 | -819.59 | Upgrade
|
| Interest & Investment Income | 991.46 | 1,082 | 564.16 | 247.17 | 80.07 | 12.38 | Upgrade
|
| Currency Exchange Gain (Loss) | 113.32 | 124.21 | -60.73 | -2.75 | -1.8 | -1.55 | Upgrade
|
| Other Non Operating Income (Expenses) | -1,207 | -1,207 | -185.76 | -0.41 | 0.61 | 247.76 | Upgrade
|
| EBT Excluding Unusual Items | -13,477 | -13,602 | -8,301 | -3,848 | -3,851 | -3,853 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | -0.04 | 8.03 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | 16.99 | - | - | Upgrade
|
| Pretax Income | -13,477 | -13,602 | -8,301 | -3,831 | -3,843 | -3,853 | Upgrade
|
| Income Tax Expense | - | - | -1,186 | - | - | - | Upgrade
|
| Net Income | -13,477 | -13,602 | -7,116 | -3,831 | -3,843 | -3,853 | Upgrade
|
| Net Income to Common | -13,477 | -13,602 | -7,116 | -3,831 | -3,843 | -3,853 | Upgrade
|
| Shares Outstanding (Basic) | 17 | 17 | 17 | 17 | 8 | 5 | Upgrade
|
| Shares Outstanding (Diluted) | 17 | 17 | 17 | 17 | 8 | 5 | Upgrade
|
| Shares Change (YoY) | -11.12% | -0.01% | 0.18% | 125.38% | 49.16% | 38.69% | Upgrade
|
| EPS (Basic) | -793.57 | -801.02 | -419.00 | -226.00 | -511.00 | -764.00 | Upgrade
|
| EPS (Diluted) | -793.57 | -801.02 | -419.00 | -226.00 | -511.00 | -764.00 | Upgrade
|
| Free Cash Flow | -10,652 | -11,534 | -6,085 | -10,555 | -3,758 | -2,658 | Upgrade
|
| Free Cash Flow Per Share | -627.19 | -679.24 | -358.31 | -622.68 | -499.67 | -527.14 | Upgrade
|
| Gross Margin | 78.77% | 78.57% | 79.99% | 58.09% | 68.90% | 100.00% | Upgrade
|
| Operating Margin | -5513.26% | -5019.47% | -2322.35% | -1510.39% | -1716.79% | -807.56% | Upgrade
|
| Profit Margin | -6237.59% | -5593.04% | -1986.19% | -1422.73% | -1681.97% | -945.20% | Upgrade
|
| Free Cash Flow Margin | -4929.82% | -4742.72% | -1698.50% | -3919.93% | -1644.68% | -652.17% | Upgrade
|
| EBITDA | -11,360 | -11,654 | -7,821 | -3,628 | -3,575 | -3,010 | Upgrade
|
| D&A For EBITDA | 552.07 | 552.46 | 499.15 | 438.88 | 348.1 | 281.6 | Upgrade
|
| EBIT | -11,912 | -12,207 | -8,320 | -4,067 | -3,923 | -3,292 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.